An outbreak case of Clostridium difficile-associated diarrhea among elderly inpatients of an intensive care unit of a tertiary hospital in Rio de Janeiro, Brazil

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 4, 2010, Pages 449-455

  Balassiano, Ilana Teruszkin ^a,b   dos Santos Filho, Joaquim ^a   de Oliveira, Márcia Pinto Barros ^c   Ramos, Maria Catarina ^d   Japiassu, Andre M ^e   dos Reis, Alessandro Mendonça ^f   Brazier, Jon S ^g   de Oliveira Ferreira, Eliane ^a   Domingues, Regina Maria Cavalcanti Pilotto ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c INFECTO Consultoria   (Brazil)

^d Serviço de Controle de Infecção Hospitalar de Hospital Terciário Privado   (Brazil)

^e Unidade de Terapia Intensiva de Hospital Terciário Privado   (Brazil)

^f Laboratório de Análises Clínicas de Hospital Terciário Privado   (Brazil)

^g UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Clostridium difficile; Clostridium difficile associated diarrhea; Elderly inpatients; Intensive care unit

Indexed keywords

CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; DNA TOPOISOMERASE (ATP HYDROLYSING) A; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM ISOLATION; BRAZIL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CROSS INFECTION; DISEASE SURVEILLANCE; EPIDEMIC; FECES ANALYSIS; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RIBOTYPING; TERTIARY HEALTH CARE;

EID: 78649232918     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.07.017     Document Type: Article

References (32)

1. Ackermann G., Tang-Feldman Y.J., Schaumann R., Henderson J.P., Rodloff A.C., Silva J., Cohen S.H. Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clin. Microbiol. Infect. 2003, 9:526-530.
2. Alcides A.P., Brazier J.S., Pinto L.J., Balassiano I.T., Boente R.F., de Paula G.R., Ferreira E.O., Avelar K.E.S., Miranda K.R., Ferreira M.C.S., Domingues R.M.C.P. New PCR ribotypes of Clostridium difficile detected in children in Brazil: prevalent types of Clostridium difficile in Brazil. Antonie Van Leeuwenhoek 2007, 92:53-59.
3. Balassiano I.T., Miranda K.R., Boente R.F., Pauer H., Oliveira I.C.M., Santos-Filho J., Amorim E.L.T., Caniné G.A., Souza C.F., Gomes M.Z.R., Ferreira E.O., Brazier J.S., Domingues R.M.C.P. Characterization of Clostridium difficile strains isolated from immunosuppressed inpatients in a hospital in Rio de Janeiro, Brazil. Anaerobe 2009, 15:61-64.
4. Barbut F., Mastrantonio P., Delmeé M., Brazier J., Kuijper J., Poxton I. Prospective study of Clostridium difficile infections in Europe phenotypic and genotypic characterisation of the isolates. Clin. Microbiol. Infect. 2007, 13:1048-1057.
5. Bourgault A.M., Lamothe F., Loo V.G., Poirier L. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada. Antimicrob. Agents Chemother. 2006, 50:3473-3475. CDAD-CSI Study Group.
6. Clinical and Laboratory Standards Institute (2007) Performance standards for antimicrobial susceptibility testing. 16th informational supplement (M100- S16). Wayne, PA: CLSI.
7. Freeman J., Bauer M.P., Baines S.D., Corver J., Fawley W.N., Goorhuis B., Kuijper E.J., Wilcox M.H. The changing epidemiology of Clostridium difficile infections. Clin. Microbiol. Rev. 2010, 23:529-549.
8. Dridi L., Tankovic J., Burghoffer B., Barbut F., Petit J.C. gyrA and gyrB mutations are implicated in cross-resistance to ciprofloxacin and moxifloxacin in Clostridium difficile. Antimicrob. Agents Chemother. 2002, 46:3418-3421.
9. Graf K., Cohrs A., Gastmeier P., Kola A., Vonberg R.P., Mattner F., Sohr F., Chaberny I.F. An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:543-545.
10. Gravel D., Miller M., Simor A., Taylor G., Gardam M., McGeer A., Hutchinson J., Moore D., Kelly S., Boyd D., Mulvey M., The Canadian Nosocomial Infection Surveillance Program Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian nosocomial infection surveillance program study. Clin. Infect. Dis. 2009, 48:568-576.
11. Goldstein E.J.C., Polonsky J., Touzani M., Citron D.M. C. difficile infection (CDI) in a long-term acute care facility (LTAC). Anaerobe 2009, 15:241-243.
12. Hookman P., Barkin J.S. Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroenterol. 2009, 15:1554-1580.
13. Huang H., Wu S., Wang M., Zhang Y., Fang H., Palmgren A.C., Weintraub A., Nord C.E. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Int. J. Antimicrob. Agents 2009, 33:339-342.
14. Huang H., Weintraub A., Fang H., Nord C.E. Antimicrobial resistance in Clostridium difficile. Int. J. Antimicrob. Agents 2009, 34:516-522.
15. Jousimies-Somer H.R., Summanen P., Citron D.M., Baron E.J., Wexler H.M., Finegold S.M. Anaerobic bacteriology manual 2002, Star Publishing Company, Belmont (CA). 6th ed.
16. Kim K.H., Fekety R., batts D.H., Brown D., Cudmore M., Silva J., Waters D. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J. Infect. Dis. 1981, 143:42-50.
17. Leclair M.A., Allard C., Lesur O., Pépin J. Clostridium difficile infection in the intensive care unit. J. Intensive Care Med. 2010, 25:23-30.
18. Lemee L., Dhalluin A., Testelin S., Mattrat M.A., Maillard K., Lemeland J.F., Pons L.J. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (toxin A), and tcdB genes for toxigenic culture of Clostridium difficile. J. Clin. Microbiol. 2004, 42:5710-5714.
19. Marcon A.P., Gamba M.A., Vianna L.A.C. Nosocomial diarrhea in the intensive care unit. Braz. J. Infect. Dis. 2006, 10:384-389.
20. McFarland L.V. Renewed interest in a difficult disease: Clostridium difficile infections-epidemiology and current treatment strategies. Curr. Opin. Gastroenterol. 2008, 25:24-35.
21. Metzger R., Swenson B.R., Bonatti H., Hedrick T.L., Hranjec T., Popovsky K.A., Pruett T.L., Sawyer R.G. Identification of risk factors for the development of Clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections. Ann. Surg. 2010, 251:722-727.
22. Mitty E. Infection control practices in assisted living communities. Geriatr. Nurs. 2009, 30:417-423.
23. Mutlu E., Wroe A.J., Sanchez-Hurtado C., Brazier J.S., Poxton I. Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland. J. Med. Microbiol. 2007, 56:921-929.
24. Pépin J., Valiquete L., Alary M.E., Villemure P., Pelletier A., Forget K., Pépin K., Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CAMJ 2004, 171:466-472.
25. Poutanen S.M., Simor A.E. Clostridium difficile-associated diarrhea in adults. CMAJ 2004, 171:51-58.
26. Riddle D.J., Dubberke E.R. Clostridium difficile infection in intensive care unit. Infect. Dis. Clin. N. Am. 2009, 23:727-743.
27. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7:526-536.
28. Spigaglia P., Barbanti F., Mastrantonio P., Brazier J.S., Barbut F., Delmée M., Kuijper E., Poxton I.R. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. J. Med. Microbiol. 2008, 57(Pt. 6):784-789. European Study Group on Clostridium difficile (ESGCD).
29. Spigaglia P., Mastrantonio P. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J. Med. Microbiol. 2004, 53:1129-1136.
30. Stubbs S.L.J., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J. Clin. Microbiol. 1999, 37:461-463.
31. Zilberberg M.D., Shorr A.F., Kolef M.H. Increase in adult Clostridium difficile-related hospitalizations and case fatality in the US, 2000-2005. Emerg. Infect. Dis. 2008, 14:929-931.
32. Zilberberg M.D., Shorr A.F., Micek S.T., Doherty J.A., Kolef M.H. Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit. Care Med. 2009, 37:2583-2589.